Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Viridian Therapeutics price target raised to $44 from $35 at RBC Capital
Premium
The Fly
Viridian Therapeutics price target raised to $44 from $35 at RBC Capital
2M ago
Viridian Therapeutics 10.67M share Secondary priced at $18.75
Premium
The Fly
Viridian Therapeutics 10.67M share Secondary priced at $18.75
2M ago
Viridian TED data adds new overhang to Amgen’s Tepezza growth, says Barclays
PremiumThe FlyViridian TED data adds new overhang to Amgen’s Tepezza growth, says Barclays
2M ago
Viridian poised to take share in TED market, says H.C. Wainwright
Premium
The Fly
Viridian poised to take share in TED market, says H.C. Wainwright
2M ago
Viridian Therapeutics price target raised to $56 from $46 at BTIG
Premium
The Fly
Viridian Therapeutics price target raised to $56 from $46 at BTIG
2M ago
Viridian Therapeutics reports Q2 EPS ($1.02) vs. ($1.27) last year
PremiumThe FlyViridian Therapeutics reports Q2 EPS ($1.02) vs. ($1.27) last year
3M ago
VRDN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VRDN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Jefferies healthcare analyst holds an analyst/industry conference call
Premium
The Fly
Jefferies healthcare analyst holds an analyst/industry conference call
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100